Skip to main content

Impact of the COVID-19 pandemic on breast cancer

Estimating the impact of the COVID-19 pandemic on breast cancer

An application on breast cancer life insurance and critical illness insurance

Duration of the Project: 2022 – 2024 (currently underway)


The project is led by Heriot-Watt University and primarily managed by Research Fellow Arık Ayşe, with support from Professor of Statistics George Streftaris, both of the Department of Actuarial Mathematics and Statistics, Heriot-Watt University, and the Maxwell Institute for Mathematical Sciences, UK.

The project is associated with ongoing research focusing on results dissemination, knowledge exchange, and conference presentations.


Steering committee

Foundation:  Zeying Peuillet and Adam Shao
Heriot-Watt University: Ayse Arik and George Streftaris

The main objectives of the related research project are to:

  • investigate how the COVID-19 pandemic, and its impact on the diagnosis of different stages of breast cancer (BC) morbidity, have affected BC mortality;
  • assess the implications of COVID-related changes to BC morbidity and mortality on related life and critical illness insurance (CII) products; and 
  • disseminate the findings to a wider community, including academic and industry parties. 

The project outputs will be submitted for publication in leading international research journals, while also being presented at international conferences and seminars.